Arcosa, Inc. (ACA) — Fair Value Analysis

Base-case fair value (P50): $137.26 · Current price: $144.97 · Verdict: Fairly Valued

The Verdict on ACA

ARCOSA INC (ACA), operating within the Industrials sector, appears Fairly Valued based on our Monte Carlo simulations. The current market price of $144.97 sits close to our median fair value (P50) estimate of $137.26. This implies a -5.3% difference against the current trading price. Our quantitative analysis suggests that, while there's no significant undervaluation or overvaluation at present, investors should consider ACA's weak quality tier relative to its Industrials peers. This 'Fairly Valued' verdict is a critical starting point for evaluating ACA, grounding expectations around its near-term price potential as indicated by our robust probabilistic models.

How ACA stacks up against Industrials

ACA's weak quality tier is a notable consideration, particularly when viewed against its Industrials sector counterparts. This tier reflects challenges in its operational and financial health compared to peers, which can temper upside potential even when the stock appears Fairly Valued. While our Monte Carlo models converge on a P50 fair value of $137.26 that is close to the current $144.97, the underlying quality profile suggests a less robust foundation. Investors should weigh this quality assessment alongside the price-to-fair-value relationship, recognizing that a -5.3% gap, even if small, is viewed in the context of the company's relative sector standing and inherent risks.

What this means for investors

For investors tracking ARCOSA INC (ACA), the Fairly Valued assessment means current prices are largely reflective of intrinsic worth based on our simulations. While the Fairly Valued verdict indicates no immediate mispricing, with a median fair value of $137.26 against a $144.97 and an implied -5.3%, significant mispricing is not evident. Given ACA's weak quality tier within the Industrials sector, potential future performance may be constrained relative to higher-quality peers, even if the current valuation seems appropriate. Investors looking for deep value or substantial upside might find ACA's current position less compelling. To gain a deeper understanding, including the full distribution of bear-case and bull-case scenarios and the probability of achieving upside, sign up for FairCurve.